AstraZeneca AB

Suède


 
Quantité totale PI 2 963
Quantité totale incluant filiales 2 963 (+ 0 pour les filiales)
Rang # Quantité totale PI 408
Note d'activité PI 3,7/5.0    1 183
Rang # Activité PI 621
Parent AstraZeneca PLC
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

467 126
215 185
1 441 129
400
 
Dernier brevet 2025 - Conjugates comprising cleavable ...
Premier brevet 1979 - Gastric acid secretion inhibitin...
Dernière marque 2025 - VERCAMTEQ
Première marque 1950 - ASTRA

Filiales

1 subsidiaries with IP (0 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations and substances.
P/S Pharmaceutical preparations and substances for the treatment of cardiovascular, metabolic, and re...
P/S Pharmaceutical preparations and substances
2024 P/S Pharmaceutical preparations and substances.
P/S Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
P/S Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
Invention Pharmaceutical compositions comprising azd9291. The present invention relates to pharmaceutical ...
Invention Amido heteroaromatic compounds. The specification relates to compounds of Formula (I): The spe...
Invention Pharmaceutical composition. The invention concerns pharmaceutical compositions containing a hydr...
Invention 2-(2,4,5-substituted-anilino)pyrimidine compounds. The present invention relates to certain 2-(2...
Invention Methods for treating chronic obstructive pulmonary disease in an enhanced patient population usin...
P/S Pharmaceutical preparations and substances for use in oncology.
P/S Pharmaceutical preparations and substances for use in oncology.
Invention Anti-pd-l1 antibodies in combinations with one or more chemotherapy agents for treating endometri...
P/S Pharmaceutical preparations and substances for use in oncology
Invention Conjugates comprising cleavable linkers. The specification relates to conjugates comprising a li...
Invention Compound azd5462 for use in the treatment of heart failure. The present disclosure relates to dos...
Invention Conjugates comprising cleavable linkers. The specification relates to conjugates comprising a lin...
Invention Crystalline irak4 inhibitors. NRrRNHNSrSNHH-indazole-5-carboxamide (Compound (II)).
Invention Anthracycline derivatives and conjugates and uses thereof. The specification relates to anthracyc...
Invention Halo-substituted piperidines as orexin receptor modulators. The present application relates to c...
P/S Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for t...
Invention Cd123 antibody-drug conjugates and methods of using the same. The present disclosure generally r...
Invention Cd123 antibody-drug conjugates and methods of using the same. The present disclosure generally re...
Invention 2,4,6-trisubstituted 1,3,5-triazines as modulators of cx3cr1. There are disclosed certain 2,4,6-...
Invention Multivalent cargo-carrying complexes and uses thereof. Provided are multivalent saccharide-conta...
Invention Multivalent cargo-carrying complexes and uses thereof. Provided are multivalent saccharide-contai...
Invention Treatment of neurodegenerative diseases. The invention relates to a method of treating or prevent...
Invention Rsv vaccine. Provided herein is a vaccine against RSV. The vaccine comprises an mRNA encoding a ...
Invention Rsv vaccine. Provided herein is a vaccine against RSV. The vaccine comprises an mRNA encoding a s...
Invention Chemical compounds. The specification relates to compounds of Formula (I): The specification r...
Invention Modified cell. Provided are hypoimmunogenic cells and methods of manufacturing such.
Invention Lilrb2 binding proteins and uses thereof. The present disclosure relates to binding proteins (e.g...
Invention Molecular switches. Provided herein are compositions and methods that permit the controlled inter...
Invention Tissue regeneration. Populations of cells for use in the treatment of kidney disease and methods ...
Invention 3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octane derivatives as smarca...
Invention Smarca2 degraders and uses thereof. The present disclosure provides compounds represented by Form...
Invention Armored t cells. This disclosure relates to compositions and methods for treating cancer using po...
Invention Pyrrolopyrimidine carboxamides. Pyrrolopyrimidine carboxamides and pharmaceutically acceptable sa...
Invention Methods, compositions, and combinations for the treatment of ovarian cancer. The disclosure relat...
Invention Pharmaceutical compositions. The present specification relates to pharmaceutical compositions com...
Invention Treatment of lupus. The disclosure relates to methods and compositions for the treatment of SLE. ...
Invention Methods and combinations for treating cervical cancer. The disclosure relates to methods, combina...
Invention Anti-ifnar1 dosing regime for subcutaneous injection. The disclosure relates to methods and comp...
P/S Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and s...
P/S Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders.
Invention Egfr tkis for use in the treatment of non-small lung cancer. The specification relates to epider...
Invention Compositions and methods for improving the efficacy of cas9-based knock-in strategies. The prese...
2023 Invention Use of inhibitors to increase efficiency of crispr/cas insertions. The present disclosure provid...
2022 Invention Compositions, methods and systems for aerosol drug delivery. 1. A pharmaceutical composition del...
Invention Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators. There are disclosed certain 3-a...
Invention Peptide dendrons and methods of use thereof. The specification relates to peptide dendrons compr...
Invention Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators. There are disclosed certain...
Invention Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulator. Th...
Invention Devices and a system for detection and analysis of inhaler use. Devices, methods and a system fo...
Invention Ca s9 effector proteins with enhanced stability. Provided are Cas9 effector proteins having enha...